Reading this on a mobile device? Try our optimized mobile version here:

January 7, 2013
Sign upForwardArchiveAdvertise

  Top Stories 
  • Lantheus extends SPECT agents deal with Japanese firm
    Lantheus Medical Imaging has renewed its long-term licensing and distribution deal with Fujifilm RI Pharma covering SPECT imaging agents Cardiolite and Neurolite. As part of the 10-year deal, which took effect Jan. 1, Lantheus will keep providing FRI with the agents in finished form for distribution in Japan. Lantheus will also supply raw materials for developing and marketing in unit dose format. (free registration) (1/3) LinkedInFacebookTwitterEmail this Story
  • Study: Patient knowledge of radiation exposure from scans lacking
    More than 50% of patients have not heard about medical imaging radiation in the news, according to a research letter published in JAMA Internal Medicine. Among patients who were aware of radiation exposure from CT and SPECT scans, 88% were not concerned about radiation and 85% underestimated how much radiation exposure was involved, the study said. "These data suggest that many patients have a limited ability to make well-informed decisions about imaging that involves radiation," researchers said. (1/2) LinkedInFacebookTwitterEmail this Story
  • Other News
  Medical Focus 
  • Many people don't know all risks of obesity, survey shows
    More than 70% of people surveyed correctly identified heart disease and diabetes as two serious consequences of obesity, but only about 15% mentioned arthritis and 7% said cancer, according to a poll by The Associated Press-NORC Center for Public Affairs Research. The survey showed that about 25% of people said it is possible to be healthy while very overweight, and 52% said they had talked with a physician about the health risks of being overweight. (Tampa, Fla.)/The Associated Press (1/6) LinkedInFacebookTwitterEmail this Story
  • Diabetic retinopathy tied to heart risks in study
    Diabetes patients with severe retinopathy were more likely to develop cardiovascular problems than those with mild retinopathy and those without the eye condition, according to a study published in Diabetes Care. Researchers also found the risk of heart trouble increased as retinopathy progressed. (1/2) LinkedInFacebookTwitterEmail this Story
  Regulatory & Policy 
  • Effort to repeal 2.3% device tax will continue, AdvaMed says
    The 2.3% medical device tax has taken effect after Congress reached a deal Tuesday to prevent the "fiscal cliff." The industry, however, has vowed to continue the push to repeal the levy. Stephen Ubl, president and CEO of the Advanced Medical Technology Association, said the effort has bipartisan support "premised on the recognition that the tax is costing jobs and threatening patient care." (Boston) (1/2) LinkedInFacebookTwitterEmail this Story
  • Minn. group aims to reverse changes to 510(k) process
    The Minnesota Medical Device Alliance has filed a petition asking the FDA to discontinue certain definitions and administrative measures that the group says unlawfully alter the 510(k) clearance process. The petition cites practices adopted by the FDA since 2009, including wrongly applying "assurance case" and risk mitigation principles to 510(k) criteria. (1/4) LinkedInFacebookTwitterEmail this Story
  ASNC News 
  • The fiscal cliff: A summary of relevant provisions
    Congress reached a deal to avert many aspects of the fiscal cliff. Vice President Joseph Biden and Senate Minority Leader Mitch McConnell, R-Ky., brokered an agreement that was ultimately passed by the Senate and the House of Representatives. While the legislation averts scheduled reductions to Medicare reimbursement rates, challenges remain. LinkedInFacebookTwitterEmail this Story
  • NC Today program brings value to your nuclear cardiology lab
    ASNC understands that nuclear physicians and technologists face unique challenges in today's health care environment. This is why ASNC is pleased to offer its popular Nuclear Cardiology Today program, April 26-28 in Fort Lauderdale, Fla., for physicians and technologists. This program will "bring value to your nuclear lab" by offering the most up-to-date protocols in imaging procedures. All physicians and technologists practicing nuclear cardiology will also want to learn about new procedures that reduce radiation dose and cutting-edge technologies that provide optimal testing. Register today for "Nuclear Cardiology Today: Bringing Value to Your Nuclear Cardiology Lab" by going to LinkedInFacebookTwitterEmail this Story
Learn more about ASNC ->ASNC Home | Join ASNC | Education and Meetings
Annual Meeting | Journal of Nuclear Cardiology

Live as if you were to die tomorrow. Learn as if you were to live forever."
--Mahatma Gandhi,
Indian lawyer and activist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent ASNC SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information